The Turkish Coronavirus vaccine, What do we know so far?

Turkish Coronavirus vaccine

Turkish President Recep Tayyip Erdogan announced that efforts to develop a domestic Turkish Coronavirus vaccine against the emerging Covid-19 virus are progressing rapidly.

Erdogan’s announcement came in statements confirming that rapid progress has been made in developing a local vaccine against Coronavirus.

and the President had previously announced in a speech he delivered at a meeting of the parliamentary bloc of his “Justice and Development” party in the capital, Ankara, that the local vaccine for the Coronavirus has reached an advanced stage, indicating that his country will present it For all of humanity.

What is the name of this vaccine? And who developed it? Follow the article to know all the details.

What is the name of the Turkish Coronavirus Vaccine?

The Turkish vaccine for the emerging coronavirus is called ERUCOV-VAC, after the name of the developer, which is Erciyes University.

Who developed the vaccine?

The Turkish Coronavirus vaccine was developed by the “Erciyes University”, through the University’s Vaccine Research and Development Center, and with the support of the Turkish Ministry of Health.

What is its type?

The vaccine depends on the technology of the inactivated vaccine, which provides for treating the infectious agents of the emerging coronavirus chemically or through heat and losing their danger, but while preserving their ability to produce an immune response.

When did the clinical trials of the Turkish Coronavirus vaccine begin?

On November 5, the University of Erciyes announced the administration of the first dose of the vaccine to a volunteer. She added that she had obtained the necessary permissions in order to start testing it in humans.

According to the statement, the university president, Mustafa Çalış, explained that the Vaccine Development Center has started the first phase of vaccine trials on humans.

He also added that the phase will last for two months, and that it is planned to end on January 5th, explaining that it will move to the next stages upon successful completion.

Where did the experiments lead?

On November 23, Professor Mustafa Çalış, President of the University, announced that the number of volunteers to try the locally developed vaccine to combat Corona virus reached 44 people, confirming that no side effects appeared to any of them.

Çalış stated that they are continuing with the first phase of the trial of the supposed vaccine, expressing confidence that they will soon skip it.

He added, “Today we gave 44 volunteers doses of the supposed vaccine, and fortunately none of them showed any side effects,” explaining that what matters in the first stage is safety, indicating that their verification takes them to the second stage, which, according to him, seems to be taking place soon.

On November 26, Turkish Health Minister Fahrettin Koca announced that his country had started giving volunteers a second dose of a possible local anti-Coronavirus vaccine.

In his tweet on Twitter, Health Minister Fahrettin Koca confirmed that Turkey is also making an effort to develop an anti-Corona vaccine, similar to other countries, and indicated that the Council is still developing the details of the strategy, as it is expected to reveal it within 7-10 days, provided that Vaccines are distributed to health workers and critical cases.

He added, “With the support of the Turkish Institutes of Health, studies of the Coronavirus vaccine developed at Erciyes University continue, according to the planned schedule.”

He also said, “Volunteers are starting to get the second dose of the possible Turkish Coronavirus vaccine. We are optimistic.”

When will the vaccine be ready?

According to the statements of Turkish President Recep Tayyip Erdogan, they aim to make the vaccine available for use next April at the latest.

Stressing that his country seeks “to provide the Turkish Coronavirus vaccine that we have developed to all of humanity” and explained that Turkey is closely following all the vaccines developed in China, Russia, the United States and Europe, In reference to projects that have reached the implementation stage.